LLY

939

-0.18%↓

JNJ

185.88

-0.41%↓

UNH

326.5

-0.01%↓

NVS

126.44

+0.65%↑

ABT

124.05

-0.64%↓

LLY

939

-0.18%↓

JNJ

185.88

-0.41%↓

UNH

326.5

-0.01%↓

NVS

126.44

+0.65%↑

ABT

124.05

-0.64%↓

LLY

939

-0.18%↓

JNJ

185.88

-0.41%↓

UNH

326.5

-0.01%↓

NVS

126.44

+0.65%↑

ABT

124.05

-0.64%↓

LLY

939

-0.18%↓

JNJ

185.88

-0.41%↓

UNH

326.5

-0.01%↓

NVS

126.44

+0.65%↑

ABT

124.05

-0.64%↓

LLY

939

-0.18%↓

JNJ

185.88

-0.41%↓

UNH

326.5

-0.01%↓

NVS

126.44

+0.65%↑

ABT

124.05

-0.64%↓

Search

Moleculin Biotech Inc

Open

0.45 -6.25

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.44

Max

0.49

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+1234% upside

Moleculin Biotech Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Nov. 2025, 23:51 UTC

Ergebnisse

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5. Nov. 2025, 23:10 UTC

Ergebnisse

DBS Third Quarter Net Dips 2.0%

5. Nov. 2025, 22:55 UTC

Ergebnisse

Arm Holdings 2Q Profit Climbs on Record Demand

5. Nov. 2025, 22:23 UTC

Ergebnisse

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5. Nov. 2025, 23:52 UTC

Ergebnisse

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5. Nov. 2025, 23:49 UTC

Ergebnisse

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5. Nov. 2025, 23:49 UTC

Ergebnisse

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5. Nov. 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5. Nov. 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5. Nov. 2025, 23:12 UTC

Ergebnisse

Nutrien 3Q Adj EPS 97c >NTR.T

5. Nov. 2025, 23:11 UTC

Ergebnisse

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5. Nov. 2025, 23:10 UTC

Ergebnisse

Nutrien 3Q Sales $6.01B >NTR.T

5. Nov. 2025, 23:10 UTC

Market Talk
Ergebnisse

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5. Nov. 2025, 23:10 UTC

Ergebnisse

Nutrien 3Q EPS 96c >NTR.T

5. Nov. 2025, 23:04 UTC

Ergebnisse

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5. Nov. 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5. Nov. 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5. Nov. 2025, 22:55 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5. Nov. 2025, 22:51 UTC

Ergebnisse

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5. Nov. 2025, 22:50 UTC

Ergebnisse

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5. Nov. 2025, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5. Nov. 2025, 22:43 UTC

Market Talk
Ergebnisse

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5. Nov. 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5. Nov. 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5. Nov. 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5. Nov. 2025, 22:12 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5. Nov. 2025, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5. Nov. 2025, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Responds to Delaware Chancery Court Ruling

5. Nov. 2025, 22:01 UTC

Ergebnisse

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5. Nov. 2025, 22:01 UTC

Ergebnisse

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Peer-Vergleich

Kursveränderung

Moleculin Biotech Inc Prognose

Kursziel

By TipRanks

1234% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD  1234%

Hoch 12 USD

Tief 4 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Moleculin Biotech Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

$

help-icon Live chat